Skip to main content

Table 4 Plasma fatty acids of overweight and obese older adults in control and olive oil groups at baseline and month 3a

From: Cardio-metabolic and immunological impacts of extra virgin olive oil consumption in overweight and obese older adults: a randomized controlled trial

  Control (N = 20)   Olive Oil (N = 20)  
Fatty Acids Baseline Month 3   Baseline Month 3 P *
    %    
C18:1n9 (OA) 19 ± 1 18 ± 1   19 ± 1 20 ± 1 0.04
Total n-3 5 ± 1 5 ± 1   4 ± 0.3 4 ± 0.3 0.38
Total n-6 43 ± 1 42 ± 1   43 ± 1 41 ± 0.3 0.31
Total PUFA 47 ± 1 47 ± 1   47 ± 1 45 ± 1 0.04
Total MUFA 22 ± 1 22 ± 1   22 ± 1 24 ± 1 0.04
Total SFA 31 ± 0.4 31 ± 1   31 ± 1 32 ± 1 0.47
OA/PUFA (ratio) 0.4 ± 0.02 0.4 ± 0.02   0.4 ± 0.02 0.5 ± 0.02 0.03
n-6/n-3 (ratio) 13 ± 1 12 ± 1   12 ± 1 12 ± 1 0.58
ALA 0.6 ± 0.03 0.6 ± 0.04   0.6 ± 0.04 0.6 ± 0.1 0.45
  1. Abbreviations: ALA alpha linolenic acid, MUFA monounsaturated fatty acids, OA oleic acid, PUFA polyunsaturated fatty acids, SFA saturated fatty acids
  2. * P-value for difference between two groups was obtained by ANCOVA adjusting for age, sex and baseline value
  3. aValues are mean ± SEM